News and Policies
Jiangsu cooperates with UK biopharma company in medical IoT
Updated: Aug 18, 2017
chinadaily.com.cn
Print
Share - WeChat
 |
| Li Qiang (R) takes a photo with Pascal Soriot (L) during their meeting on Aug 15 in Nanjing, capital of Jiangsu province. [Photo/ jstv.com] |
Li said that as a global leading science-led biopharmaceutical business, AstraZeneca has achieved remarkable progress in investment in Jiangsu and the government will continue to support its projects in Taizhou and Wuxi, and enhance the protection of its intellectual property rights.
He also hoped to deepen cooperation with AstraZeneca in biological medicine and medical IoT.
Soriot introduced AstraZeneca's development conditions in Jiangsu and said that the company feels confident in Jiangsu. It will actively promote its cooperation with Jiangsu in medicine R&D and medical IoT by making full use of its advantages so as to create more cooperative results.
MOST POPULAR
- 1 $39.7 billion worth of deals inked at Airshow China
- 2 China announces tax relief measures to stabilize real estate sector
- 3 A look at China's economy in October, 2024
- 4 Public holiday extension announced
- 5 China's NEV annual production hits 10 million milestone amid global carbon reduction efforts
Editors' Picks
Infographic:
Golden jubilee of China-Brazil relations
Infographic:
A look at China's economy in October 2024
